earnings
Novartis Q1 earnings drop as cancer drug sales falter
April 21, 2016Business Services, Sales and Marketing Financial, Novartis, earnings, first quarter, results
Swiss drugmaker Novartis (SIX: NOVN) on Thursday reported a 13% drop in net income for the first quarter on the …
Boehringer Ingelheim posts 11% rise in FY15 sales boosted by diabetes business
April 20, 2016Business Services, Research and Development, Sales and Marketing Boehringer Ingelheim, FY, earnings, forecasts, outlook, results
Boehringer Ingelheim reported 11% jump in sales for 2015 driven by its diabetes business and said for 2016 it sees …
J&J raises FY outlook, Q1 beats estimates
April 20, 2016Business Services, Research and Development, Sales and Marketing Financial, Johnson & Johnson, Q1, earnings, results, revenue, sales
Healthcare giant Johnson & Johnson (NYSE: JNJ) raised its full-year outlook and posted first-quarter earnings ahead of estimates despite currency headwinds. …
Roche reports 5% rise in Q1 sales boosted by cancer drugs
April 19, 2016Manufacturing and Production, Sales and Marketing Q1, Roche, earnings, oncology drugs, results
Oncology drug maker Roche (VTX: ROG) on Tuesday reported 5% increase in first-quarter sales driven by cancer drugs. The company …
Latest content
Femtosecond laser cuts lung tumour margin assessment time
October 15, 2026
Blood sensor detects Parkinson’s-associated proteins in 40 minutes
October 15, 2026
Ofichem acquires US drug substance CDMO Kinentia
October 14, 2026
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
October 13, 2026
